CSL reports Phase III data for garadacimab to treat hereditary angioedema
According to the findings, the trial of garadacimab met the primary and secondary efficacy objectives.
Australia
Latest in
Australia
Odyssey reports positive data from Phase I concussion trial
According to the safety findings, PRV-002 was found to be safe and well tolerated in this cohort.
Hutchmed’s Phase III colorectal cancer trial meets primary endpoint
Fruquintinib’s safety profile in this trial was in line with priorly reported data from trials.
Seelos doses first subject in ALS basket trial in Australia
The open-label basket study in Australia will analyse SLS-005’s impact on disease progression and severity.
Invex approved to start Phase III idiopathic intracranial hypertension trial
The trial will analyse the safety and efficacy of Presendin compared to placebo in IIH patients over 24 weeks.
EnGeneIC’s Covid-19 vaccine offers protection against variants in trials
Increased neutralising antibody levels against all variants, including Omicron BA2, and memory response were observed in subjects.
Kiora gets approval to begin Phase Ib retinitis pigmentosa trial
The open-label, first-in-human, single ascending dose trial will analyse KIO-301 in individuals with retinitis pigmentosa.
Government of Victoria breaks ground on new melanoma trials centre
The Government of Victoria in Australia has broken ground on the new melanoma and clinical trials centre.